A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Alpha Tau Medical targets major 2026 catalysts as Alpha DaRT gains momentum; key pancreatic & GBM readouts ahead. Read the full analysis here of DRTS stock.

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

A groundbreaking study at Rabin Medical Center suggests prostate cancer patients may need only two radiation doses, ...

DelveInsight's PSMA-targeted Therapy Market Size, Target Population, Competitive Landscape & Market Forecast report includes ...

In the first-ever study, Australian researchers have demonstrated the feasibility and safety of using stabilised hyaluronic ...

Australian researchers have successfully demonstrated the safety and feasibility of using stabilised hyaluronic acid gel in radiation treatment for gynaecological cancers. This world-first study found ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

"This study is a world-first in exploring stabilised hyaluronic acid (sHA) gel's potential to improve outcomes for patients ...

Australian researchers has demonstrated that the feasibility and safety of using stabilised hyaluronic acid (sHA) gel during ...